Tag: FDA adverse event reporting
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Drug Take-Back Programs in Your Community: How They Work
Jun, 3 2026
Digestive Enzymes: When Supplements May Help GI Symptoms
Jan, 21 2026
Why Lupus Support Groups Matter for Discoid and Systemic Lupus Patients
Oct, 17 2025
How to Build an Effective Asthma Action Plan for Better Control
Apr, 8 2026
Genetic Factors That Increase Susceptibility to Drug Side Effects
Dec, 20 2025